Last $0.0061 USD
Change Today -0.0009 / -12.86%
Volume 20.0K
QMDT On Other Exchanges
As of 3:51 PM 09/16/14 All times are local (Market data is delayed by at least 15 minutes).

quick-med technologies inc (QMDT) Snapshot

Previous Close
Day High
Day Low
52 Week High
09/30/13 - $0.10
52 Week Low
09/4/14 - $0.0046
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

quick-med technologies inc (QMDT) Related Businessweek News

No Related Businessweek News Found

quick-med technologies inc (QMDT) Details

Quick-Med Technologies, Inc., a life sciences company, focuses on developing and commercializing proprietary broad-based technologies in medical and consumer healthcare markets. It specializes in the research and development of biomedical products and devices for antibacterial applications. The company’s core technologies include Novel Intrinsically Micro-Bonded Utility Substrate (NIMBUS), a family of advanced polymers with antimicrobial, hemostatic, and other properties for use in a range of applications; Stay Fresh, a chemical formulation for textiles with a durable antimicrobial agent effective against an array of bacteria; and MultiStat, a family of advanced patented methods and compounds effective in skin therapy applications. It serves government agencies; and healthcare and medical, apparel and textile, and personal care companies. The company was founded in 1997 and is headquartered in Gainesville, Florida.

5 Employees
Last Reported Date: 09/30/13
Founded in 1997

quick-med technologies inc (QMDT) Top Compensated Officers

Principal Executive Officer, President and Di...
Total Annual Compensation: $126.1K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $80.3K
Compensation as of Fiscal Year 2013.

quick-med technologies inc (QMDT) Key Developments

Quick-Med Technologies Inc. Signs License with Medline Industries, Inc. to Provide Stay-Fresh(R) Antimicrobial Technology for Traditional Wound Care Products

Quick-Med Technologies, Inc. announced that it has licensed its Stay Fresh(R) technology to Medline Industries, Inc. for use in traditional wound care products for both retail and institutional sale in the North American market.

Quick-Med Technologies, Inc. Licenses its Stay Fresh Technology to Sarasota Medical Products for Use in Ostomy and Wound Care Products

Quick-Med Technologies Inc. announced that it has licensed its Stay Fresh(R) technology to Sarasota Medical Products (SMP) for use in Hydrocolloids in SMP's Ostomy and Advanced Wound Care product lines. Quick-Med's antimicrobial technology will greatly expand the number of patients that can provide with safe, effective antimicrobial products in support of infection prevention and control programs. These technologies are specifically designed to be effective against resistant organisms like MRSA, and to prevent new resistant bacteria from emerging. This is the initial commercial application of Quick-Med's newest Stay Fresh format: an antimicrobial superabsorbent powder (SAP) that can be directly substituted for a conventional SAP to provide strong and durable antimicrobial activity in applications including health care and hygiene.

Quick-Med Technologies Files Form 15

Quick-Med Technologies Inc. has announced that it has filed a Form 15 with the Securities and Exchange Commission to voluntarily deregister its common stock, par value $0.001 per share under the Securities Exchange Act of 1934, as amended.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
QMDT:US $0.01 USD -0.0009

QMDT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Johnson & Johnson $105.88 USD +1.16
View Industry Companies

Industry Analysis


Industry Average

Valuation QMDT Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.3x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact QUICK-MED TECHNOLOGIES INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at